Morenzo Abadi Perkasa Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Morenzo Abadi Perkasa Tbk. trades at Rp68 (market cap 149.22B, 2.17M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.09M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 3.9× Morenzo Abadi Perkasa Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.09M versus 2.17M). Which is the better fit depends on your goals.
| ENZO | LABS | |
|---|---|---|
Market Cap | 149.22B | 576.7B |
Volume | 2.17M | 3.09M |
Lot | 21.72K | 30.89K |
Turnover | 147.89M | 464.84M |
Average Price | 68.08 | 150.47 |
Value | 147.89M | 464.84M |
Indicative Equilibrium Price | 69 | 147 |
Indicative Equilibrium Volume | 66K | 311 |
Trailing returns across standard periods
Latest headlines on both assets
PT Morenzo Abadi Perkasa Tbk, (The “Company”) was established based on Notarial Deed No. 21 of Jhon Langsung, S.H., dated January 10, 2013. Company commenced its commercial business activities in 2013. PT Tritunggal Sukses Investama is the ultimate Parent Entity and Parent Entity of the Company and Mr. Markus Silitonga as the ultimate shareholder.
Read more on ENZO →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →